细胞衰老,与衰老相关的分泌表型,以及癌症
Larissa G P Langhi Prata1, Tamar Tchkonia1, James L Kirkland1,2
1Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States of America.
PLoS biology
|September 21, 2023
概括
细胞衰老,一种由压力诱导的细胞命运,涉及一种可以驱动炎症和癌症的分泌表型. 这一发现为开发针对衰老细胞的老化药物铺平了道路.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 细胞衰老是一种稳定的细胞循环停止,由各种细胞应激引发.
- 衰老相关的分泌表型 (SASP) 是衰老细胞的一个关键特征.
- SASP可以影响瘤微环境和全身炎症.
研究的目的:
- 研究细胞衰老在促进炎症和癌症中的作用.
- 了解老化相关的分泌表现型 (SASP) 的含义.
- 探索针对老化的细胞进行治疗的潜力.
主要方法:
- 审查关于细胞衰老和SASP的现有文献.
- 分析SASP对炎症通路的影响.
- 检查衰老,炎症和癌症发展之间的联系.
主要成果:
- 细胞衰老可以由各种细胞应激引起.
- 与衰老相关的分泌表型 (SASP) 导致慢性炎症.
- SASP可以促进瘤发生和癌症的进展.
- 对SASP的理解使得 senolytic药物的开发成为可能.
结论:
- 细胞衰老及其相关的分泌表型在炎症和癌症中发挥着关键作用.
- 通过老化药物向衰老细胞是一个有前途的治疗策略.
相关概念视频
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


